In a pooled analysis of multiple short-term, placebo-controlled studies of CNS stimulants, psychotic or manic symptoms occurred in approximately 0.1% of CNS stimulant-treated patients compared to 0% of placebo-treated patients
We refuse to be strong-armed by any pharmaceutical companys anticompetitive demands that infringe on the independent decision making of providers and limit patient choice. We are disappointed to see Novo Nordisk management misleading the public
Typically, the effects of a single injection may last from a few days to a week
this product is not intended to diagnose, treat, cure, or prevent any disease
Its positive effect on glutathione might even help in managing psychiatric and neurological conditions like ADHD, autism, addiction, and Alzheimers